Maximizing the value of electronic prescription monitoring programs

Electronic prescription monitoring programs have been established in approximately seventeen states, and legislation has been introduced into Congress that would create a national program. The goal of these programs is to reduce controlled substance diversion, without adversely affecting the appropriate use of controlled substances for pain and other medical conditions. This article questions whether this goal is being achieved and offers five key factors that can maximize the value of electronic prescription monitoring programs: comprehensiveness, expert analysis, timely and meaningful feedback, clear standards, and periodic program review.